GeNeDiS 2016
View: 541
Website |
Edit Freely
Category
Deadline: September 20, 2016 | Date: October 20, 2016-October 23, 2016
Venue/Country: Sparta, Greece
Updated: 2016-04-09 08:46:17 (GMT+9)
Call For Papers - CFP
For the second time three of the most modern and popular scientific areas are brought together in a conference in Greece, at the 2nd World Congress on Genetics, Geriatrics and Neurodegenerative Disease research. Nobel laureates, leading scientists and researchers from all over the world will discuss the recent developments in these areas, ranging from research progress and the latest scientific discoveries to the clinical and pharmaceutical applications. Call for PapersThe Scientific Program Committee of the 2nd World Congress on Genetics, Geriatrics and Neurodegenerative Diseases Research (GeNeDis 2016) cordially invites you to submit papers for oral and poster presentations. Papers should be submitted online. All papers will be reviewed by the scientific program committee and assigned to the appropriate session for oral and poster presentations.Submitted papers will be refereed by at least two reviewers for quality, correctness, originality, and relevance. Accepted papers will be presented at the conference and included in the proceedings. You will soon be informed about the series title book for the publication of our proceedings.Paper Submission Deadline: June 20, 2016All aspects of the submission and notification process will be handled online via theEasyChair Conference System at: https://easychair.org/conferences/?conf=genedis2016 .Authors are invited to electronically submit original, English-language research contributions or experience reports no longer than 10 pages formatted according to the well-known LNCS Springer style. Submitted papers must present unpublished work, not being considered for publication in other journals or conferences.Submission GuidelinesAll presenting authors of accepted papers are expected to attend the congress and register no later than September 20, 2016.1. Papers should be submitted online.2. Papers should be submitted in English.3. The maximum number of pages is 10.4. Authors may further edit and modify submitted papers until the submission deadline. It is the responsibility of the authors to ensure that their text does not contain typos or grammatical errors.5. No proofreading will be carried out, and no corrections will be possible after the submission deadline.6. Authors have the option of choosing their presentation type (oral / poster / workshop /round table). However, the scientific program committee will make the final decision.Topics for Oral & Poster presentations are open to all fields related to ageingNotification of AcceptanceAll submitted abstracts will be reviewed by the Scientific Program Committee according to standard reviewing procedures.Notification of Paper Acceptance: July 20, 2016Early Registration: August 20, 2016GeNeDis 2016 will focus on a strong scientific program combined with teaching, training and live workshops to inform and educate scientist on the latest major challenges in scientific research, the new drug targets, the development of novel biomarkers, the new imaging techniques and the novel protocols for early diagnosis of neurodegenerative diseases, and several other scientific advances. GeNeDis 2016 will feature an internationally recognized widely diverse program, that will contribute in attracting delegates to attend this major event.The conference proceedings will be published by Springer in the Series: Advances in Experimental Medicine and Biology (AEMB), 2012- Impact Factor: 1.825.It will be a great honour for us to join us delivering a talk on this subject. This conference has been established to share the relevant visions, missions and strategies in the three scientific fields, and by participating you will have the chance to contribute to the main goal of the conference.Last but not east, we kindly ask you to inform your colleagues for possible attendance to the meeting and to include information in your calendar events of your website.Topics • Geriatrics • Neurodegenerative Diseases• Cognition and memory• Dementia• Brain Disorders • RNA and diseases• Sleeping disorders• Chronic diseases• Mental health • Biopsychiatry• Psychiatric diseases• Neuroimaging • Clinical neurophysiology• Brain physiology• Genomic and electrophysiology• Transcriptome sequencing • Clinical genetics and genomics• System Biology• Signal processing in Neurodegenerative diseases• Biomedical text processing• Genome engineering• Computational biology• Computational epigenomics• Big data and genome medicine• Therapeutic applications of genome editing• Stem cell research and development • Cell therapy• Biomarkers• Diagnostic of human disease biomarkers• gene expression analysis• Neuropharmacology• Pharmacogenetics• Diagnostic protocols and testsCongress Program Planning(1) Bioinformatics and Human Electrophysiology Laboratory, (BiHELab), Department of Informatics, Ionian University, Greece http://bihelab.di.ionio.gr/ (2) Computational Modeling Laboratory, (CMODLab), Department of Informatics, Ionian University, Greecehttp://di.ionio.gr/el/research/laboratories/computational-modelling-lab-cmodlab.html (3) Department of Informatics, Ionian University, Greecehttp://di.ionio.gr/en (4) University of Peloponnese, Greece http://www.uop.gr/ (5) Technological Educational Institute of Ionian Islands, Greecehttp://www.teiion.gr/index.php/en.html (6) CARGO lab, Wilfrid Laurier University, Waterloo, Ontario, Canadahttp://www.cargo.wlu.ca/ (7) Region of Peloponnese, Greece http://ppel.gov.gr/
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.